ReviewGlobal health & medicine2024
A policy overview of Japan's progress on dementia care in a super-aged society and future challenges.
Review in Global health & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Efficacy of 42-month oral administration of glucoraphanin in preventing cognitive decline in individuals at elevated risk of dementia, including those with mild cognitive impairment: a randomized, double-blind, placebo-controlled pilot study.Frontiers in nutrition · 2026Trial
- Article
- The growing burden of dementia in Asia: Comparative insights from Japan, China, and India.The journal of prevention of Alzheimer's disease · 2026Article
- Medical Challenges in Caring for Older Adults With Type 2 Diabetes and Dementia: A Qualitative Interview Study Using SCAT to Compare Primary Care Physicians and Diabetes Specialists in Japan.Journal of general and family medicine · 2026Article
- From companion technologies to social care infrastructure: A multi-level perspective on loneliness-related support in dementia care in an era of artificial intelligence (AI).Global health & medicine · 2026Article
- Dementia Care in an Aging World: Achievements, Challenges, and Future Directions.Geriatrics & gerontology international · 2026Review
- Gender differences in informal caregiving costs and burden in Alzheimer disease: a multinational cross-sectional analysis.BMC public health · 2026Article
- Association Between the Color Kanji Pick-Out Test App Performance and Cognitive Frailty as a Potential Early Screening Marker for Cognitive Decline.Geriatrics (Basel, Switzerland) · 2026Article
- Article
- A literature review of dementia literacy in China: From awareness to action as a driver of the 2024-2030 National Dementia Action Plan.General psychiatry · 2026Review
- Personal and Family Perspectives Regarding Neurodegenerative Disorder Risk.Journal of community medicine & public health · 2026Article
- Digital health platforms for intrinsic capacity monitoring in community-based integrated care for older adults: a scoping review.Frontiers in public health · 2026Article
- Bridging Dementia Care in Japan: The Emerging Role of General Medicine Physicians.Journal of clinical medicine · 2025Review
- Early Alzheimer's disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries.The journal of prevention of Alzheimer's disease · 2025Review
- Qualitative study of stakeholder perspectives on dementia policy implementation in Macao: progress, challenges and future directions.BMJ open · 2025Article
- Improving care for people with dementia through co-creation of action plans in the Western Pacific region.BMJ (Clinical research ed.) · 2025Article
- Alzheimer's disease and dementia in Japan: Epidemiological trends, regional disparities, and future projections.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Missing incidents and the risk of harm in persons living with dementia reported to the Swedish police- A nationwide retrospective registry study.BMC geriatrics · 2025Article
- Article
- Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dementia is highly prevalent in Japan, a super-aged society where almost a third of the population is above 65 years old. Japan has been implementing ageing and dementia policies since 2000 and now has a wealth of experience to share with other nations who are anticipating a similar future regarding dementia. This article focuses on the 2019 National Framework for Promotion of Dementia Policies that, based on its philosophy of Inclusion and Risk Reduction, lays out five complementary strategies. Together, these five strategies encourage a whole of society approach in dementia care. We first elaborate on the activities being undertaken under each of these strategies and then discuss the future challenges that Japan needs to address. These policy and social innovations spearheaded by Japan can be useful information for other countries that are anticipating similar future as Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.